Sickle Cell Disease for Health Professionals

Clinical Practice Guidelines

The IOM (2011) defined clinical practice guidelines as "statements that include recommendations intended to optimize patient care that are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options."

RELATED NEWS

An example of what the InCharge Health app would look like on a smartphone.
|
Research Feature
A new smartphone app could be a boon for adolescents, young adults When the Food and Drug Administration (FDA) approved the drug hydroxyurea to help reduce the excruciating pain suffered by people with sickle cell disease, the health care community was hopeful. The year was 1998, and the prospect of a drug that could offer significant relief from the devastating effects of a disease that had no cure seemed promising. Only thing, patients would have to take the drug as prescribed to fully reap its benefits. And in the decades since its approval, that has proven to be more of a challenge than...

RELATED EVENT

Sickle Cell In Focus Conference 2019 Logo
October 10 - 11, 2019
Jamaica Pegasus Hotel
81 Knutsford Boulevard
Kingston 5, Jamaica West Indies

After another successful event at the NIH/NHLBI, USA, in October 2018, we are pleased to announce that Sickle Cell ...